These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2772483)

  • 1. Possible role of free radical altered IgG in the etiopathogenesis of rheumatoid arthritis.
    Swaak AJ; Kleinveld HA; Kloster JF; Hack CE
    Rheumatol Int; 1989; 9(1):1-6. PubMed ID: 2772483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG3 reactive rheumatoid factor in rheumatoid arthritis: etiologic and pathogenic considerations.
    Wong A; Kenny TP; Ermel R; Robbins DL
    Autoimmunity; 1994; 19(3):199-210. PubMed ID: 7541651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen free radicals denature human IgG and increase its reactivity with rheumatoid factor antibody.
    Lunec J; Griffiths HR; Brailsford S
    Scand J Rheumatol Suppl; 1988; 75():140-7. PubMed ID: 3238348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation of rheumatoid factors.
    Williams RC; Malone CC; Casali P
    J Immunol; 1992 Sep; 149(5):1817-24. PubMed ID: 1380541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte Fc receptor function in rheumatoid arthritis. Enhanced cell-binding of IgG induced by rheumatoid factors.
    MacKinnon SK; Starkebaum G
    Arthritis Rheum; 1987 May; 30(5):498-506. PubMed ID: 3593433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis.
    Miyata M; Sato Y; Kasukawa R
    J Rheumatol; 1999 Jul; 26(7):1436-8. PubMed ID: 10405926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal IgG rheumatoid factors from the synovial tissue of patients with rheumatoid arthritis.
    Randen I; Thompson KM; Thorpe SJ; Førre O; Natvig JB
    Scand J Immunol; 1993 Jun; 37(6):668-72. PubMed ID: 8316765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.
    Schmid FR; Roitt IM; Rocha MJ
    J Exp Med; 1970 Oct; 132(4):673-93. PubMed ID: 5508376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymorph derived oxidants on IgG in relation to rheumatoid factor binding.
    Griffiths HR; Lunec J
    Scand J Rheumatol Suppl; 1988; 75():148-56. PubMed ID: 2853449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation.
    Matsumoto A; Shikata K; Takeuchi F; Kojima N; Mizuochi T
    J Biochem; 2000 Oct; 128(4):621-8. PubMed ID: 11011144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.
    Sato Y; Watanabe H; Kogure A; Miyata M; Watanabe K; Nishimaki T; Kasukawa R; Fujita T
    Clin Rheumatol; 1995 Jul; 14(4):425-8. PubMed ID: 7586979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.
    Bonagura VR; Artandi SE; Davidson A; Randen I; Agostino N; Thompson K; Natvig JB; Morrison SL
    J Immunol; 1993 Oct; 151(7):3840-52. PubMed ID: 7690818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
    Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
    Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential reactivity of rheumatoid synovial cells and serum rheumatoid factors to human immunoglobulin G subclasses 1 and 3 and their CH3 domains in rheumatoid arthritis.
    Robbins DL; Benisek WF; Benjamini E; Wistar R
    Arthritis Rheum; 1987 May; 30(5):489-97. PubMed ID: 3593432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.